IL41347A - Mineral salt preparation - Google Patents
Mineral salt preparationInfo
- Publication number
- IL41347A IL41347A IL41347A IL4134773A IL41347A IL 41347 A IL41347 A IL 41347A IL 41347 A IL41347 A IL 41347A IL 4134773 A IL4134773 A IL 4134773A IL 41347 A IL41347 A IL 41347A
- Authority
- IL
- Israel
- Prior art keywords
- weight
- mineral salt
- vitamin
- parts
- inclusive
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract 20
- 238000002360 preparation method Methods 0.000 title claims abstract 19
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract 16
- 239000011707 mineral Substances 0.000 title claims abstract 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract 7
- 229910019142 PO4 Inorganic materials 0.000 claims abstract 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract 7
- 239000011575 calcium Substances 0.000 claims abstract 7
- 229910052791 calcium Inorganic materials 0.000 claims abstract 7
- 239000011777 magnesium Substances 0.000 claims abstract 7
- 229910052749 magnesium Inorganic materials 0.000 claims abstract 7
- 235000021317 phosphate Nutrition 0.000 claims abstract 7
- 239000011591 potassium Substances 0.000 claims abstract 7
- 229910052700 potassium Inorganic materials 0.000 claims abstract 7
- 239000011734 sodium Substances 0.000 claims abstract 7
- 229910052708 sodium Inorganic materials 0.000 claims abstract 7
- 235000000346 sugar Nutrition 0.000 claims abstract 7
- 229930003231 vitamin Natural products 0.000 claims abstract 6
- 239000011782 vitamin Substances 0.000 claims abstract 6
- 229940088594 vitamin Drugs 0.000 claims abstract 6
- 235000013343 vitamin Nutrition 0.000 claims abstract 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract 5
- 239000002671 adjuvant Substances 0.000 claims abstract 5
- 239000000654 additive Substances 0.000 claims abstract 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract 3
- 229930091371 Fructose Natural products 0.000 claims abstract 3
- 239000005715 Fructose Substances 0.000 claims abstract 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract 3
- 229930195725 Mannitol Natural products 0.000 claims abstract 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract 3
- 229930006000 Sucrose Natural products 0.000 claims abstract 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract 3
- 229930003268 Vitamin C Natural products 0.000 claims abstract 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract 3
- 235000013681 dietary sucrose Nutrition 0.000 claims abstract 3
- 235000003599 food sweetener Nutrition 0.000 claims abstract 3
- 239000008187 granular material Substances 0.000 claims abstract 3
- 239000008101 lactose Substances 0.000 claims abstract 3
- 239000000594 mannitol Substances 0.000 claims abstract 3
- 235000010355 mannitol Nutrition 0.000 claims abstract 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract 3
- 239000000600 sorbitol Substances 0.000 claims abstract 3
- 235000010356 sorbitol Nutrition 0.000 claims abstract 3
- 229960004793 sucrose Drugs 0.000 claims abstract 3
- 239000003765 sweetening agent Substances 0.000 claims abstract 3
- 235000019154 vitamin C Nutrition 0.000 claims abstract 3
- 239000011718 vitamin C Substances 0.000 claims abstract 3
- 239000000811 xylitol Substances 0.000 claims abstract 3
- 235000010447 xylitol Nutrition 0.000 claims abstract 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract 3
- 229960002675 xylitol Drugs 0.000 claims abstract 3
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims abstract 2
- 239000002934 diuretic Substances 0.000 claims abstract 2
- 229940030606 diuretics Drugs 0.000 claims abstract 2
- 230000005068 transpiration Effects 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 5
- 239000010452 phosphate Substances 0.000 claims 5
- 150000003722 vitamin derivatives Chemical class 0.000 claims 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 2
- 229930003471 Vitamin B2 Natural products 0.000 claims 2
- 150000001450 anions Chemical class 0.000 claims 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 claims 2
- 229960002477 riboflavin Drugs 0.000 claims 2
- 235000019164 vitamin B2 Nutrition 0.000 claims 2
- 239000011716 vitamin B2 Substances 0.000 claims 2
- 229930003451 Vitamin B1 Natural products 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229960003966 nicotinamide Drugs 0.000 claims 1
- 235000005152 nicotinamide Nutrition 0.000 claims 1
- 239000011570 nicotinamide Substances 0.000 claims 1
- 229960003495 thiamine Drugs 0.000 claims 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 1
- 235000010374 vitamin B1 Nutrition 0.000 claims 1
- 239000011691 vitamin B1 Substances 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
- 229940046009 vitamin E Drugs 0.000 claims 1
- 229940104757 vitamin E 50 mg Drugs 0.000 claims 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Substances OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 2
- -1 drag es Substances 0.000 abstract 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 abstract 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 abstract 1
- GHOKWGTUZJEAQD-SSDOTTSWSA-N 3-[[(2s)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoic acid Chemical class OCC(C)(C)[C@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-SSDOTTSWSA-N 0.000 abstract 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- 101000653791 Bos taurus Protein S100-A12 Proteins 0.000 abstract 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 abstract 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 abstract 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract 1
- 239000004150 EU approved colour Substances 0.000 abstract 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-M L-ascorbate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CIWBSHSKHKDKBQ-JLAZNSOCSA-M 0.000 abstract 1
- 150000000994 L-ascorbates Chemical class 0.000 abstract 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 239000000872 buffer Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000007938 effervescent tablet Substances 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 150000002315 glycerophosphates Chemical class 0.000 abstract 1
- 235000001968 nicotinic acid Nutrition 0.000 abstract 1
- 229960003512 nicotinic acid Drugs 0.000 abstract 1
- 239000011664 nicotinic acid Substances 0.000 abstract 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 abstract 1
- 230000003204 osmotic effect Effects 0.000 abstract 1
- 229940055726 pantothenic acid Drugs 0.000 abstract 1
- 235000019161 pantothenic acid Nutrition 0.000 abstract 1
- 239000011713 pantothenic acid Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 150000008163 sugars Chemical class 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 239000011975 tartaric acid Substances 0.000 abstract 1
- 235000002906 tartaric acid Nutrition 0.000 abstract 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 abstract 1
- 239000000080 wetting agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Inorganic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
1356096 Mineral salt preparations F HOFFMANN-LA ROCHE & CO AG 23 Feb 1973 [25 Feb 1972] 9053/73 Heading A5B Mineral salt preparations for the replacement of minerals lost by bodily stress and increased transpiration as well as by the use of diuretics, contain in the form of salts, 1 to 16 parts by weight of calcium, 1 to 8 parts by weight of magnesium, 0.4 to 4 parts by weight of potassium and no sodium or less than 0.1 parts by weight of sodium, the calcium, potassium, magnesium and sodium constituting more than 2% by weight of the preparation. The salts may be the appropriate carbonates, phosphates, glycerophosphates, gluconates, ascorbates or D-pantothenates. The preparations may be administered orally in the form of powders, granulates, tablets (e.g. effervescent tablets), drag es, capsules, solutions, suspensions or emulsions. The preparations may also contain phosphates, vitamins, e.g. vitamin C, B 1 , B 2 , B 6 and E, nicotinic acid, nicotinamide, pantothenic acid and/or calcium D-pantothenate; sugars, e.g. glucose, lactose, fructose, saccharose, laevulose, mannitol, sorbitol or xylitol; sweetening agents; aroma additives; acid additives, e.g. citric or tartaric acid, colouring agents; solubilising agents; granulating adjuvants, preservatives; stabilisers; wetting agents; emulsifiers; salts for varying the osmotic pressure and/or buffers.
[GB1356096A]
Claims (2)
1. 41347/2
2. ) Process according to claim " 1, wherein a part of the salts, which contain calcium, magnesium, potassium and, if necessary, sodium, is phosphate and wherein the amount of phosphate used is 2 to 2 parts by weight. -3) Process according to claim .1 or claim 2, wherein vitamins and/or adjuvants are added* A) Process according to any one of claims .1 to ~ inclusive, wherein aroma additives are added. -5) Process according to any one of claims .1 to A inclusive, wherein a sweetening agent is added. 41347^2 .6) Process according to any one of claims , 1 to Γ-5 inclusive, wherein- he- mineral, salt preparation is manufactured in the form of a water-soluble granulate,, .7) Process according to any one of claims 1 to .6 inclusive, wherein a sugar is added. .8) Process according to claim 7 » wherein said sugar is fructose, saccharose , laevulose or lactose. . 9) Process according to claim .7 » wherein said sugar is sorbitol , mannitol and/or xylitol. lO), Process according to any one of claims \ to 9 inclusive , wherein salts containing a total, of 250 mg of calcium, 170 mg of magnesium, lOOmg of potassium,' 310 mg of phosphate and other anions are mixed with 500 mg of vitamin C , 10 mg of vitamin 15 m of vitamin B2 , mg of vitamin B^ , 20 mg of nicotinamide , 20 mg o f calcium D--pantothenate , 50 mg of vitamin E and adjuvants to 10, 000 mg. 11) Mineral salt preparation for the replacement of minerals lost by bodily stress and increased transpiration as well as by the use of diuretics, said preparation containing, in the form of salts, 1 to 16 parts by weight of calcium, 1 to 8 parts by weight of magnesium, 0.4- to parts by weight of potassium and no sodium or less than · 0.1 parts by weight of sodium; the weight ratio of calcium, 41^47/2 potassium, magnesium and sodium to the total weight of the preparation lying above 2%. 2 j) Mineral salt preparation according to contains 2 to 2 parts by weight of phosphate. 13) Mineral salt preparation according to clairn H or claim 22 which contains vitamins and/or adjuvants. 4 ) Mineral salt preparation according to any one of claims 11 to 15 inclusive which contains an aroma additive. 15 ) Mineral salt preparation according to any one of claims n to 14 inclusive whioh contains a sweetening agent 16 ) Mineral salt preparation according to any one of claims 11 to 15! inclusive which is present in the form of a water-soluble granulate. 17 ) Mineral salt preparation according to any one of claims 11 to 16 inclusive which contains a sugar. 18) Mineral salt preparation according to claim 17 , wherein said sugar is fructose, saccharose, laevulose or lactose. 19) Mineral salt preparation according to claim- l'7 t wherein said sugar is sorbitol, mannitol and/or xylitol. 20) Mineral salt preparation according to any one of claims H to 16 inclusive of the following compositions Vitamin C 500 mg Vitamin B1 10 mg Vitamin B2 15 mg Vitamin Bg 25 mg Nicotinamide 20 mg Clacium D-pantothenate 20 mg Vitamin E 50 mg Calcium 250 mg Magnesium 170 mg Potassium 100 mg Phosphate 310 mg together with other anions and adjuvants to 10, 000 mg. For the Applicants
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH271972 | 1972-02-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL41347A0 IL41347A0 (en) | 1973-03-30 |
| IL41347A true IL41347A (en) | 1976-04-30 |
Family
ID=4240056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL41347A IL41347A (en) | 1972-02-25 | 1973-01-19 | Mineral salt preparation |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS4896712A (en) |
| AT (1) | AT322743B (en) |
| AU (1) | AU462328B2 (en) |
| BE (1) | BE795827A (en) |
| CA (1) | CA1023991A (en) |
| DE (1) | DE2305979A1 (en) |
| FR (1) | FR2173262B1 (en) |
| GB (1) | GB1356096A (en) |
| IE (1) | IE37291B1 (en) |
| IL (1) | IL41347A (en) |
| NL (1) | NL7301864A (en) |
| PH (1) | PH9888A (en) |
| SE (1) | SE422273B (en) |
| ZA (1) | ZA73288B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI60107C (en) * | 1978-02-24 | 1982-12-13 | Suomen Laeaeketehdas Oy Salco | SOM KRYDDA ELLER SOM KONSERVERINGSMEDEL FOER LIVSMEDEL ANVAENDBAR BORDSSALTPRODUKT |
| JPS579712A (en) * | 1980-06-20 | 1982-01-19 | Fukumi Morishige | Instilling (dripping) liquid for intravenous injection |
| FI834309L (en) * | 1983-11-24 | 1985-05-25 | Pharmaconsult Oy | SALT MIXTURE. |
| HU191598B (en) * | 1984-03-20 | 1987-03-30 | Egyt Gyogyszervegyeszeti Gyar | Method for the preparation of injection solution suitable preferably against cathosis |
| US5035898A (en) * | 1987-11-27 | 1991-07-30 | Schering Corporation | Potassium/magnesium supplement |
| US9974319B2 (en) | 2006-03-29 | 2018-05-22 | Purac Biochem B.V. | Partially neutralized polycarboxylic acids for acid-sanding |
-
1973
- 1973-01-15 ZA ZA730288A patent/ZA73288B/en unknown
- 1973-01-18 AU AU51227/73A patent/AU462328B2/en not_active Expired
- 1973-01-19 IL IL41347A patent/IL41347A/en unknown
- 1973-02-07 DE DE2305979A patent/DE2305979A1/en not_active Withdrawn
- 1973-02-09 NL NL7301864A patent/NL7301864A/xx unknown
- 1973-02-19 IE IE251/73A patent/IE37291B1/en unknown
- 1973-02-23 BE BE795827D patent/BE795827A/en not_active IP Right Cessation
- 1973-02-23 SE SE7302591A patent/SE422273B/en unknown
- 1973-02-23 JP JP48021405A patent/JPS4896712A/ja active Pending
- 1973-02-23 CA CA164,471A patent/CA1023991A/en not_active Expired
- 1973-02-23 FR FR7306516A patent/FR2173262B1/fr not_active Expired
- 1973-02-23 AT AT163173A patent/AT322743B/en not_active IP Right Cessation
- 1973-02-23 GB GB905373A patent/GB1356096A/en not_active Expired
- 1973-02-25 PH PH14349*A patent/PH9888A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL41347A0 (en) | 1973-03-30 |
| FR2173262B1 (en) | 1975-10-10 |
| JPS4896712A (en) | 1973-12-10 |
| IE37291B1 (en) | 1977-06-22 |
| IE37291L (en) | 1973-08-25 |
| AT322743B (en) | 1975-06-10 |
| SE422273B (en) | 1982-03-01 |
| ZA73288B (en) | 1973-10-31 |
| AU462328B2 (en) | 1975-06-19 |
| DE2305979A1 (en) | 1973-08-30 |
| FR2173262A1 (en) | 1973-10-05 |
| NL7301864A (en) | 1973-08-28 |
| AU5122773A (en) | 1974-07-18 |
| BE795827A (en) | 1973-08-23 |
| GB1356096A (en) | 1974-06-12 |
| PH9888A (en) | 1976-06-08 |
| CA1023991A (en) | 1978-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Karlish et al. | On the Mechanism of Uncoupling in Chloroplasts by Ion‐Permeability Inducing Agents | |
| US4164568A (en) | Oral scour formulations with citrate | |
| GB1405088A (en) | Slow release formulation | |
| US2822317A (en) | Aqueous iron-ascorbic acid preparation | |
| GB1503886A (en) | Nonalcoholic beverages | |
| IL41347A (en) | Mineral salt preparation | |
| GR3004440T3 (en) | ||
| GB975387A (en) | Multivitamin compositions | |
| IE37292L (en) | Mineral salt preparation | |
| GB1344558A (en) | Method for treating diseases by coenzyme a and adenosine triphosphate and composition therefor | |
| GB2308810A (en) | Composition for combatting dehydration | |
| US3777029A (en) | Chewable multivitamin tablets contain-ing aluminum nicotinate | |
| GB1191246A (en) | Vitamin-containing Preparations | |
| JPS6479105A (en) | Powder composition for beauty culture pack of occasion preparation type | |
| ES264510A1 (en) | Improvements in or relating to pharmaceutical iron preparations | |
| DE69104294T2 (en) | Dosage forms, their manufacturing processes and their applications. | |
| GB1234328A (en) | ||
| GB883169A (en) | Dry effervescent concentrate | |
| IE38113L (en) | Anti-smoking preparations | |
| IE38383B1 (en) | Doxycline parenteral composition | |
| DE418341C (en) | Baking process | |
| JPH02240025A (en) | Stable aqueous solution of complex vitamin | |
| GB1521648A (en) | Water-soluble composition comprising sulphadimidine and pyrimethamine | |
| GB1178984A (en) | Improvements in or relating to Hepatic Medicines | |
| GB1356489A (en) | Compositions for and method of combating coccidiosis and mareks disease in poultry |